HOME > History

History
1948
Riken reorganized into Kagaku-Kenkyusho
Penicillin Kaken launched
1950
Streptomycin Kaken launched
1952
Kagaku-Kenkyusho renamed Kaken Chemicals
1953
Komagome Factory opened
Athletan (anti-trichophyton product) launched
1961
Kaken Chemicals listed on the Second Section of the Tokyo Stock Exchange
1962
Kaken Chemicals listed on the First Section of the Tokyo Stock Exchange
1963
Shizuoka Factory opened
1965
The 11th Okochi Memorial Prize received
1971
The 17th Okochi Memorial Prize received
1979
Empynase P launched
1982
Kaken Chemicals merged with Kakenyaku-Kako to form KAKEN PHARMACEUTICAL CO., LTD.
1986
Kaken Realty & Service Co., Ltd. established
1987
Artz launched
Empynase PD launched
1988
Kaken Pharma Co., Ltd. established
Adofeed launched
1989
Ebrantil launched
1992
Procylin launched
Mentax launched
1993
Artz Dispo launched
1994
The 40th Okochi Memorial Prize received
1995
Cytotec launched
The 41th Okochi Memorial Prize received
1996
Mentax approved by U.S. Food and Drug Administration
1998
50th Anniversary
Bunkyo Green Court completed
Seprafilm launched
2000
Shiga Factory closed
2001
ISO14001 obtained in Shizuoka site
Mirol launched
Fiblast Spray launched
2002
Mentax launched as OTC drug in the United States
Compliance Program instituted
2004
Mentax Spray launched
2005
GHRP KAKEN launched
bFGF-the rights to develop, manufacture and sell on a world basis obtained
2006
Licensing Agreement for Antifungal compound “KP-103” in North America and Europe
Fiblast Spray is licensed-out to South Korea
2007
Licensing Agreement for Dental Applications of bFGF in North America and Europe
Berasus launched
2008
Adfeed Pap launched
2009
License Agreement for bFGF in Wound Healing Applications in Europe and North America
2010
Clexane launched
2011
Lipidil launched
2014
Clenafin launched
Copyright(C) Kaken Pharmaceutical Co.,Ltd. All Rights Reserved.
Kaken Pharmaceutical Co.,Ltd. HOME Site map Contact Japanese